USPTO serial 79448144
AZURECELL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WILLIS, ALLYSON B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with AZURECELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrea L. Hintz
Andrea L. Hintz Resonate IP, LLCPO Box 1650Bend, OR 97709United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in cell cultures, other than for medical or veterinary use; stem cells other than for medical or veterinary use; cells other than for medical or veterinary use; cell culture reagents for scientific and research use; biological preparations, namely, fluid matrices for use in scientific and medical research; cell culture media other than for medical or veterinary use; biological preparations, namely, cell lines for scientific use; molecular genetics reagents, plasmids being small independently replicating pieces of DNA, and vectors being small independently replicating pieces of DNA that can transfer DNA sequences, being chemicals for scientific use | ACTIVE | — |
| 005 | Pharmaceutical products for the treatment of neurodegenerative disorders; diagnostic preparations for medical and veterinary use; pharmaceutical preparations for activating cellular functions; medical preparations for the treatment of the brain and nervous system, namely, neurodegenerative diseases and movement disorders; medical preparations for the treatment of Parkinson's disease; biotechnological preparations for medical use, namely, stem cell-derived cellular preparations for the treatment of neurological disorders and genetically engineered cellular preparations for the treatment of neurological disorders; biotechnological preparations for medical use, namely, gene or cell therapy; cells for medical use; living cells and living biological tissue cultures for medical use; theranostic therapeutic cells for medical purposes; surgical implants comprised of living tissues and cells; chemical or biological reagents and cell culture media for medical use; diagnostic agents for medical use; diagnostic kits comprising diagnostic agents, preparations and substances for medical use | ACTIVE | — |
| 044 | Medical services; regenerative medicine services; cultured cell bank services for medical transplantation; medical treatment services by means of cultured cells; medical treatment services by means of stem cell therapy; providing regenerative medicine services for third parties in the form of cell culture services, namely, preparation, expansion and characterization of cells to be used for therapeutic purposes; providing clinical advice on cell therapy; genetic analysis services for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 8, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 2, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 19, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 19, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 10, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 10, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 10, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 10, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 10, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 30, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 7, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 7, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 20, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 19, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 22, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |